|
Post by peppy on Mar 21, 2017 10:49:03 GMT -5
MNKD going down on relatively high volume today. 896,493 shares in 2 hours and 14 mins. As pointed out, a few high share volume sales/buys. www.nasdaq.com/symbol/mnkd/real-time
The whole market going down today. Dow Jones 20,730.03 -175.83 (-0.84%) S&P 500 2,352.15 -21.32 (-0.90%) Nasdaq 5,825.20 -76.33 (-1.29%)
Just throwing it out in the atmosphere, since the ACA looks to be taken apart, and the amount of money that pharma has gone up these last 8 years, Quantitative easing stopped.? The government situation, The market is under pressure.
Added: 1,064,160 shares in three hours. (used to be 5 million plus shares)
|
|
|
Post by dreamboatcruise on Mar 21, 2017 11:01:11 GMT -5
MNKD going down on relatively high volume today. 896,493 shares in 2 hours and 14 mins. As pointed out, a few high share volume sales/buys. www.nasdaq.com/symbol/mnkd/real-time
The whole market going down today. Dow Jones 20,730.03 -175.83 (-0.84%) S&P 500 2,352.15 -21.32 (-0.90%) Nasdaq 5,825.20 -76.33 (-1.29%)
Just throwing it out in the atmosphere, since the ACA looks to be taken apart, and the amount of money that pharma has gone up these last 8 years, Accommodative easing stopped.? The government situation, The market is under pressure.
Don't worry about pharma. Big business is quite successful about looking after there own whether the tide is coming or going in DC.
|
|
|
Post by peppy on Mar 21, 2017 11:17:55 GMT -5
yes, I know dreamboat.
|
|
|
Post by surplusvalue on Mar 21, 2017 11:35:17 GMT -5
I wouldn't expect too much change in the way that this stock trades. There was plenty of ammunition in the 10K and conference call to reinforce the beliefs of the loyal longs, but there was an equal amount of ammunition for those with the opposite view of the world. If everybody sticks to their core beliefs the longs will go longer and the short will short more, resulting in a Mexican standoff of sorts. Eventually it will become evident who was more correct, but eventually will not sort itself out for several more months. I've been long for a long time and invested way more than I should have in MNKD, but I guess my loyalty is lacking as I still don't see anything in this 10k that would make me put in more money at this point. There would need to be some meaningful sign of a path to resolving the looming insolvency before I would invest more. Agreed. Stand back and look at the big picture. The stock is around 40 cents presplit and the cash situation is limited and looming just over the horizon. Even if the scripts doubled its not even close to enough at all. They need to move product and a lot of it and it doesnt look like the US is where its going to happen. Some sort of foreign deal is needed and soon. They saved the listing but as reluctant as I am to say it the company is on life support.
|
|
|
Post by dreamboatcruise on Mar 21, 2017 11:56:49 GMT -5
I've been long for a long time and invested way more than I should have in MNKD, but I guess my loyalty is lacking as I still don't see anything in this 10k that would make me put in more money at this point. There would need to be some meaningful sign of a path to resolving the looming insolvency before I would invest more. Agreed. Stand back and look at the big picture. The stock is around 40 cents presplit and the cash situation is limited and looming just over the horizon. Even if the scripts doubled its not even close to enough at all. They need to move product and a lot of it and it doesnt look like the US is where its going to happen. Some sort of foreign deal is needed and soon. They saved the listing but as reluctant as I am to say it the company is on life support. Doubling would certainly be a good start. It's primarily the trajectory that will be important. There needs to be evidence of a steady growth in the number of doctors actively prescribing. The smart money will undoubtedly spend the time and money to actually poll physicians... as they did after approval, discovering the severe headwinds Afrezza would face long before any of us were wise to it. I believe there is a lot more detailed data that can be bought from companies like IMS. However... no growth is no growth... which is what we have now.
|
|
|
Post by brotherm1 on Mar 21, 2017 15:07:03 GMT -5
Biotechs got hammered today for some reason, MNKD was by far not alone ending down 6%
|
|
|
Post by peppy on Mar 21, 2017 15:18:35 GMT -5
Total real time MNKD volume today, 1,436,054 shares. $2.07 eod price. $2,972,631 dollars trade value. www.nasdaq.com/symbol/mnkd/real-time
In general the major USA indices, price took out the last 4 weeks of trade.
|
|
|
Post by gamblerjag on Mar 21, 2017 15:22:55 GMT -5
So just got back from Ralphs (kroger ) grocery store in Pt. Loma (San Diego) and where I know this is not a high traffic area for Afrezza I asked the pharmasist if they have had any new people on Afrezza. The guy (more foreign descent) wasn't sure what it was and I started to explain when this other pharmasist butted in to my pleasure and said " Oh the real fast insulin the that is inhaled". We talked for a few and he said that drug is amazing but he thinks insurance coverage is still the main obstacle. He didn't say that most diabetics haven't heard of that as we all here know.. but it was good to hear him say how fast it was and the reason he felt it hasn't caught on yet. He said there are about two people on it at that pharmacy. Then he said "if he sees' this catching on via insurance he will definitely buy stock in the company .. i said that is why I'm asking Of course I had to mention SNY causing much of the slow start and mentioned the Manufacture is the wonderful gentlemen that had much to do with the insulin pump.
|
|
|
Post by dreamboatcruise on Mar 21, 2017 15:53:31 GMT -5
So just got back from Ralphs (kroger ) grocery store in Pt. Loma (San Diego) and where I know this is not a high traffic area for Afrezza I asked the pharmasist if they have had any new people on Afrezza. The guy (more foreign descent) wasn't sure what it was and I started to explain when this other pharmasist butted in to my pleasure and said " Oh the real fast insulin the that is inhaled". We talked for a few and he said that drug is amazing but he thinks insurance coverage is still the main obstacle. He didn't say that most diabetics haven't heard of that as we all here know.. but it was good to hear him say how fast it was and the reason he felt it hasn't caught on yet. He said there are about two people on it at that pharmacy. Then he said "if he sees' this catching on via insurance he will definitely buy stock in the company .. i said that is why I'm asking Of course I had to mention SNY causing much of the slow start and mentioned the Manufacture is the wonderful gentlemen that had much to do with the insulin pump. I wonder how "fresh" his experiences are with regard to insurance being declined. Progress has been made. Granted, the poor Medicare coverage is still a significant problem, and unfortunately it seems not changing until 2018. If you talk to him again ask what % of coverage would make him invest. Not that I really know where we are for Afrezza at this point.
|
|
|
Post by seanismorris on Mar 21, 2017 16:13:55 GMT -5
The conclusion I reached, from the conversation with the pharmacist, is that we're investing in biotech wrong...
We should all become pharmacists to get the inside information. That's one job that could be a gold mine...
|
|
|
Post by nylefty on Mar 21, 2017 16:26:34 GMT -5
So just got back from Ralphs (kroger ) grocery store in Pt. Loma (San Diego) and where I know this is not a high traffic area for Afrezza I asked the pharmasist if they have had any new people on Afrezza. The guy (more foreign descent) wasn't sure what it was and I started to explain when this other pharmasist butted in to my pleasure and said " Oh the real fast insulin the that is inhaled". We talked for a few and he said that drug is amazing but he thinks insurance coverage is still the main obstacle. He didn't say that most diabetics haven't heard of that as we all here know.. but it was good to hear him say how fast it was and the reason he felt it hasn't caught on yet. He said there are about two people on it at that pharmacy. Then he said "if he sees' this catching on via insurance he will definitely buy stock in the company .. i said that is why I'm asking There are 67 thousand pharmacies in the United States. If they all had two people on Afrezza I'd be a happy dawg.
|
|
|
Post by dreamboatcruise on Mar 21, 2017 20:27:36 GMT -5
The conclusion I reached, from the conversation with the pharmacist, is that we're investing in biotech wrong... We should all become pharmacists to get the inside information. That's one job that could be a gold mine... Though we have all known the very poor script numbers for a long time. I'm presuming even if I were a pharmacist it wouldn't have improved my poor processing of the information available. I have a friend that is a pharmacist that I told about Afrezza, and after he checked around he said he wouldn't invest in it.
|
|
|
Post by porkini on Mar 21, 2017 23:27:10 GMT -5
The conclusion I reached, from the conversation with the pharmacist, is that we're investing in biotech wrong... We should all become pharmacists to get the inside information. That's one job that could be a gold mine... Though we have all known the very poor script numbers for a long time. I'm presuming even if I were a pharmacist it wouldn't have improved my poor processing of the information available. I have a friend that is a pharmacist that I told about Afrezza, and after he checked around he said he wouldn't invest in it. dbc - not sniping at you here, but was your pharmacist friend checking around on other prescription numbers or looking at the efficacy of the product? I know, the weekly numbers need to go up, that is painfully clear...
|
|
|
Post by sportsrancho on Mar 22, 2017 7:51:50 GMT -5
The conclusion I reached, from the conversation with the pharmacist, is that we're investing in biotech wrong... We should all become pharmacists to get the inside information. That's one job that could be a gold mine... Though we have all known the very poor script numbers for a long time. I'm presuming even if I were a pharmacist it wouldn't have improved my poor processing of the information available. I have a friend that is a pharmacist that I told about Afrezza, and after he checked around he said he wouldn't invest in it. With all the places he checked.. How many Afrezza scripts were being filled? And has anyone else asked at their pharmacy?
|
|
|
Post by peppy on Mar 22, 2017 8:31:31 GMT -5
Though we have all known the very poor script numbers for a long time. I'm presuming even if I were a pharmacist it wouldn't have improved my poor processing of the information available. I have a friend that is a pharmacist that I told about Afrezza, and after he checked around he said he wouldn't invest in it. With all the places he checked.. How many Afrezza scripts were being filled? And has anyone else asked at their pharmacy? I live in a backwards state. I called the university and large endo's in the metropolis a year and a half ago, none of them were prescribing afrezza. I think I know the answer in this location. We like to delude ourselves here and think we are above the rest. The random sample we have is good, because it was a San Diego pharmacy? California seems to be ahead of the rest of us. I see your point so many times over sports. Believe me. (Don't ask, don't tell) Let's see what healthcare becomes after the changes from hell to increase the returns of the private health insurance industry paid for in political campaign donations and hate. I will stop.
|
|